Pregledni rad

Immunotherapy of urinary bladder carcinoma

Dag Zahirović ; Clinic for Radiotherapy and Oncology, Clinical Hospital Center Rijeka, Rijeka, Croatia
Ira Pavlović Ružić ; Clinic for Radiotherapy and Oncology, Clinical Hospital Center Rijeka, Rijeka, Croatia
Ingrid Belac Lovasić ; Clinic for Radiotherapy and Oncology, Clinical Hospital Center Rijeka, Rijeka, Croatia

Sažetak

Urothelial urinary bladder carcinoma represents 9th most common malignancy in the world. This disease is held responsable for more than 165000 deaths throughout the world. In the past 30 years there were no major advances in treatment of this tumor. Chemotherapy regimens used for treatment are based on platinum compounds. In a recent time a series of immune system modulating drugs have been developed. This drugs have achieved excellent results in the treatment of urinary bladder carcinoma.

Ključne riječi

urothelial carcinoma; immunotherapy; checkpoint inhibitors

Hrčak ID:

192130

URI

https://hrcak.srce.hr/192130

Datum izdavanja:

21.12.2017.

Podaci na drugim jezicima: hrvatski

Posjeta: 1.444 *